Show simple item record

dc.contributor.authorMatthaios, D.
dc.contributor.authorTolia, M.
dc.contributor.authorMauri, D.
dc.contributor.authorKamposioras, K.
dc.contributor.authorKaramouzis, M.
dc.date.accessioned2022-01-31T15:49:09Z
dc.date.available2022-01-31T15:49:09Z
dc.date.issued2021en
dc.identifier.citationMatthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 2021;9(12):13.en
dc.identifier.pmid34944765en
dc.identifier.doi10.3390/biomedicines9121949en
dc.identifier.urihttp://hdl.handle.net/10541/625031
dc.description.abstractHippo pathway with its main molecule YAP is a crucial pathway for development, tissue homeostasis, wound healing, tissue regeneration, and cancer. In this review, we discuss the multiple effects of the YAP/Hippo pathway in the immune system and cancer. We analyzed a series of effects: extracellular vesicles enhanced immunity through inhibition of LATS1/2, ways of modulation of the tumor microenvironment, YAP- and TAZ-mediated upregulation of PDL1, high expression of YAP and PDL1 in EGFR-TKI-resistant cells, enhanced YAP activity in inflammation, and the effect of the Hippo pathway on T cells, B cells, Tregs, macrophages, and myeloid-derived suppressor cells (MDSCs). These pleiotropic effects render the YAP and Hippo pathway a key pathway for exploitation in the future, in order to enhance our immunotherapy treatment strategies in oncology.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.3390/biomedicines9121949en
dc.titleYAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tangoen
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Rhodes General Hospital, 85100 Rhodes, Greeceen
dc.identifier.journalBiomedicinesen
dc.description.noteen]
refterms.dateFOA2022-04-19T12:34:41Z


Files in this item

Thumbnail
Name:
34944765.pdf
Size:
540.6Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record